Home
Conditions
Diabetes Mellitus

Clinical trial condition

Diabetes Mellitus

Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

6,409 public trials 526 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus trial results

Completed

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

NCT00825253

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

NCT00313001

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Plainsboro, New Jersey, United States

View Trial Details

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects

NCT01527656

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

NCT00624364

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Bloemfontein, Free State, South Africa

Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa

Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa

Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa

View all 15 locations

View Trial Details

Completed

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

NCT00612599

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Århus C, Denmark

View Trial Details

Completed

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

NCT00824668

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

NCT01536028

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

NCT00127296

Conditions: Delivery Systems, Diabetes, Diabetes Mellitus, +5 more
Locations: Novo Nordisk Investigational Site San Antonio, Texas, United States

View Trial Details

Completed

Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

NCT01548235

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Copenhagen S, Denmark

View Trial Details

Completed

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

NCT01487811

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site San Antonio, Texas, United States

View Trial Details

Diabetes Mellitus

Diabetes Mellitus trial results

Related conditions